Enter assignee name

Trademarks = 3

Forward Citations = 55

Loading Chart...

6 inventors (with patents filed for the assignee):

John M Rudey (17 out of 20 patents)

James A Tumlin (16 out of 19 patents)

Paul L Darke (13 out of 14 patents)

4. Keith E Drouet (3 out of 3 patents)

5. Sam L Nguyen (2 out of 4 patents)

6. Eric Stephen Gruff (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12514871 - Pegylated menaquinol compositions and methods of treatment (2026-01-06),

2. 12433854 - Methods and compositions for preventing or treating calciphylaxis (2025-10-07),

3. 12377060 - Methods and compositions for preventing or treating tissue calcification (2025-08-05),

4. 12103914 - Compositions of biologically active menaquinol derivatives and methods of treatment (2024-10-01),

5. 11793773 - Methods and compositions for preventing or treating calciphylaxis (2023-10-24),

6. 11723882 - Methods and compositions for preventing or treating tissue calcification (2023-08-15),

7. 11603345 - Menaquinol compositions and methods of treatment (2023-03-14),

8. 11332427 - Menaquinol compositions and methods of treatment (2022-05-17),

9. 11065212 - Methods and compositions for preventing or treating calciphylaxis (2021-07-20),

10. 11033515 - Methods and compositions for preventing or treating tissue calcification (2021-06-15),

11. 10987320 - Methods and compositions for preventing or treating calciphylaxis (2021-04-27),

12. 10940123 - Methods and compositions for preventing or treating calciphylaxis (2021-03-09),

13. 10925838 - Methods and compositions for preventing or treating calciphylaxis (2021-02-23),

14. 10874623 - Methods and compositions for preventing or treating tissue calcification (2020-12-29),

15. 10822295 - Menaquinol compositions and methods of treatment (2020-11-03),

Epizon Pharma, Inc. is a biopharmaceutical company based in New York, specializing in the development and commercialization of innovative therapies for various medical conditions. The organization focuses on advancing drug candidates through rigorous research and development processes, with an emphasis on addressing unmet medical needs. Epizon Pharma is committed to leveraging cutting-edge technologies and scientific expertise to enhance patient outcomes and contribute to the evolving landscape of healthcare solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

18 Patents

#434 in New York, NY

#1,051 in New York

#17,933 in US

#34,146 in the World

New York, NY, United States of America

Epizon Pharma, Inc.